Evidence map›Paper›PMID 28750034›Full record

ArticlePloS one2017

A modified FASP protocol for high-throughput preparation of protein samples for mass spectrometry.

Jeremy Potriquet, Marut Laohaviroj, Jeffrey M Bethony, Jason Mulvenna

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Cytotoxic Effect ofCancer management and research · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Infection withParasitology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeremy PotriquetGenetics & Computational Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, 4060, Australia.
Marut LaohavirojDepartment of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Jeffrey M BethonyDepartment of Microbiology, Immunology and Tropical Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC 20052, United States of America.ORCID http://orcid.org/0000-0002-7901-2113
Jason MulvennaGenetics & Computational Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, 4060, Australia.

Funding

Biomarkers of Opisthorchis viverrini-induced cholangiocarcinomaR01CA155297 · NCI · GEORGE WASHINGTON UNIVERSITY · PI BETHONY, JEFFREY MICHAEL, BRINDLEY, PAUL J · 2011 to 2015
$2.7M
Pathogenesis of Opisthorchiasis induced persistent periductal fibrosis and CCAP50AI098639 · NIAID · KHON KAEN UNIVERSITY · PI SRIPA, BANCHOB · 2012 to 2016
$1.6M
NCI NIH HHS R01 CA155297NIAID NIH HHS P50 AI098639
6 · The paper itself

Abstract

To facilitate high-throughput proteomic analyses we have developed a modified FASP protocol which improves the rate at which protein samples can be processed prior to mass spectrometry. Adapting the original FASP protocol to a 96-well format necessitates extended spin times for buffer exchange due to the low centrifugation speeds tolerated by these devices. However, by using 96-well plates with a more robust polyethersulfone molecular weight cutoff membrane, instead of the cellulose membranes typically used in these devices, we could use isopropanol as a wetting agent, decreasing spin times required for buffer exchange from an hour to 30 minutes. In a typical work flow used in our laboratory this equates to a reduction of 3 hours per plate, providing processing times similar to FASP for the processing of up to 96 samples per plate. To test whether our modified protocol produced similar results to FASP and other FASP-like protocols we compared the performance of our modified protocol to the original FASP and the more recently described eFASP and MStern-blot. We show that all FASP-like methods, including our modified protocol, display similar performance in terms of proteins identified and reproducibility. Our results show that our modified FASP protocol is an efficient method for the high-throughput processing of protein samples for mass spectral analysis.

Indexed as

Cell LineHigh-Throughput Screening AssaysHumansHydrophobic and Hydrophilic InteractionsMass SpectrometryMembranes, ArtificialPolymersProteinsProteomicsSulfonesMembranes, Artificialpolyether sulfonePolymersProteinsSulfones

Identifiers

PMID28750034
PMCPMC5531558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.